These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1717021)

  • 1. Prenatal diagnosis of structural abnormalities.
    Sanders RC
    Curr Opin Obstet Gynecol; 1991 Apr; 3(2):259-65. PubMed ID: 1717021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
    Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of pathological alpha-1-fetoprotein levels in the framework of prenatal diagnosis].
    Casper F; Möbus V; Wellek S; Gehm D; Seufert R; Brockerhoff P; Kreienberg R
    Z Geburtshilfe Perinatol; 1992; 196(1):7-10. PubMed ID: 1372459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
    Warner AA; Pettenati MJ; Burton BK
    Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha fetoprotein in maternal serum in pregnancies with trisomy 18].
    Dix U; Gams M; Grubisic A; Dericks-Tan JS; Langenbeck U
    Z Geburtshilfe Perinatol; 1988; 192(5):231-3. PubMed ID: 2463716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein.
    Drugan A; Dvorin E; Obrien JE; Johnson MP; Evans MI
    Curr Opin Obstet Gynecol; 1991 Apr; 3(2):230-4. PubMed ID: 1717020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noninvasive screening for chromosome abnormalities in young pregnant patients].
    Schmid W
    Arch Gynecol Obstet; 1992; 252 Suppl():S36-43. PubMed ID: 1482204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of aneuploidy and unexplained elevated maternal serum alpha-fetoprotein.
    Hiett AK; Callaghan CM; Brown HL; Golichowski AM; Heerema NA
    J Perinatol; 1998; 18(5):343-6. PubMed ID: 9766408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
    Kaffe S; Hsu LY
    Am J Med Genet; 1992 Apr; 42(6):801-6. PubMed ID: 1372793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
    Campbell TL
    J Fam Pract; 1987 Nov; 25(5):461-7. PubMed ID: 2445897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.